Can Glucagon-like peptide-1 (GLP-1) analogs decrease vitamin B12 levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 23, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

GLP-1 Receptor Agonists and Vitamin B12 Levels

GLP-1 receptor agonists do not directly decrease vitamin B12 levels, but monitoring vitamin B12 is recommended when patients are on concurrent metformin therapy, which is commonly prescribed alongside GLP-1 receptor agonists.

Relationship Between GLP-1 RAs and Vitamin B12

GLP-1 receptor agonists (GLP-1 RAs) are a class of medications used for treating type 2 diabetes and, more recently, obesity. Based on current guidelines and evidence:

  • No direct association between GLP-1 RAs and vitamin B12 deficiency has been established in clinical guidelines 1
  • Major diabetes management guidelines do not list vitamin B12 deficiency as a side effect of GLP-1 RAs 1
  • The common side effects of GLP-1 RAs include:
    • Gastrointestinal symptoms (nausea, vomiting, diarrhea) 1
    • Delayed gastric emptying 1
    • Dehydration (particularly with liraglutide, dulaglutide, semaglutide, and tirzepatide) 2

Metformin and Vitamin B12 Connection

The confusion may arise because GLP-1 RAs are often prescribed alongside metformin, which is known to cause vitamin B12 deficiency:

  • Metformin is associated with vitamin B12 deficiency with long-term use 1
  • KDIGO guidelines (2022) explicitly recommend: "Monitor patients for vitamin B12 deficiency when they are treated with metformin for more than 4 years" 1
  • The American Diabetes Association Standards of Care (2021) notes: "A randomized trial confirmed previous observations that metformin use is associated with vitamin B12 deficiency and worsening of symptoms of neuropathy" 1

Clinical Implications and Recommendations

When prescribing GLP-1 RAs in diabetes management:

  1. Monitor vitamin B12 levels in patients who are on concurrent metformin therapy, especially after 4 years of use 1

  2. Be aware of potential symptoms of vitamin B12 deficiency:

    • Peripheral neuropathy
    • Anemia
    • Cognitive changes

  3. Consider the medication regimen as a whole:

    • Most patients with type 2 diabetes on GLP-1 RAs are also taking metformin as first-line therapy 1
    • The treatment algorithm for type 2 diabetes typically includes metformin as the foundation, with GLP-1 RAs added when glycemic targets are not achieved 1

Special Considerations

Interestingly, there is emerging research exploring the conjugation of GLP-1 RAs with vitamin B12 to potentially reduce gastrointestinal side effects 3. This suggests that vitamin B12 may actually have a beneficial interaction with GLP-1 RAs rather than being depleted by them.

While monitoring vitamin B12 levels is not specifically required for patients taking only GLP-1 RAs, it is prudent to monitor vitamin B12 in patients on combination therapy that includes metformin, especially in those with risk factors for deficiency or symptoms suggestive of neuropathy.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Should Zofran (Ondansetron) be prescribed to help patients tolerate GLP-1 (Glucagon-like peptide-1) receptor agonist therapy?
What steps can be taken to alleviate gassiness in a patient with type 2 diabetes on a Glucagon-like peptide-1 (GLP-1) receptor agonist?
In a 38-year-old male smoker with type 2 diabetes mellitus with elevated HbA1c despite metformin, a sodium‑glucose cotransporter‑2 inhibitor, a dipeptidyl peptidase‑4 inhibitor and basal insulin; uncontrolled hypertension on perindopril; markedly elevated low‑density lipoprotein cholesterol despite statin; class II obesity; impaired renal function; and osteoarthritis, which of the following is the most appropriate next treatment: bariatric surgery, glucagon‑like peptide‑1 receptor agonist, phentermine, or very‑low‑calorie diet?
Is it okay to add glipizide (a sulfonylurea) 5 mg to a 48-year-old patient with type 2 diabetes on Lantus (insulin glargine) 23 units, 1:10 carb ratio, and Farxiga (dapagliflozin) 10 mg, who does not want to start mealtime insulin or GLP-1 receptor agonists?
Does a patient with pre-diabetes and a BMI of 25.5 qualify for a GLP-1 receptor agonist?
Is clonidine (hypertension medication) still used to treat hypertension (HTN)?
What is the duration of antitubercular (anti-tuberculosis) therapy in a patient with a tuberculosis infection in a knee prosthesis?
What is the typical dose of clonidine (antihypertensive medication) for hypertension upon discharge from the emergency department (ED)?
What is the preferred imaging modality between PSMA (Prostate Specific Membrane Antigen) PET/CT scan and Whole Body Scan for diagnosing prostate cancer?
What is the initial treatment for myositis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question